Most Read Articles
Elvira Manzano, Yesterday
Monthly injections of the PCSK9* monoclonal antibody evolocumab effectively reduced plasma LDL-cholesterol (LDL-C), often referred to as the bad cholesterol, in teenagers with heterozygous familial hypercholesterolaemia (HeFH) already taking statins, with or without ezetimibe, the HAUSER-RCT has shown.
Jairia Dela Cruz, Yesterday
For individual with type 2 diabetes, losing weight is everything when it comes to improving the metabolic function, and it matters little whether this is achieved by dieting or undergoing bariatric surgery, according to a small study.
Jairia Dela Cruz, 16 Sep 2020
In patients with heart failure with reduced ejection fraction (HFrEF) receiving angiotensin-converting-enzyme (ACE) inhibitors, high dosing confers benefits for the risk of death or hospitalization that are similar to that obtained with lower dosing, according to a systematic review and meta-analysis.
Pearl Toh, 21 Sep 2020
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.

Adjuvant chemotherapy declining in men undergoing retroperitoneal lymph node dissection

26 Jun 2020

The last decade has seen minimal use of adjuvant chemotherapy following primary retroperitoneal lymph node dissection (RPLND), according to a recent study. The majority (81 percent) of men with pathological stage (PS)-II disease have been cured with RPLND alone and have been able to avoid chemotherapy.

Patients who underwent primary RPLND between January 2007 and December 2017 were identified via retrospective review of the Indiana University testis cancer database. The authors contacted patients and providers to obtain information regarding adjuvant therapy, recurrence, and survival. Recurrence-free survival was the primary endpoint, and survival differences were assessed using Kaplan-Meier curves stratified by PS, template of dissection, and use of adjuvant chemotherapy.

Of the 274 men included in the study, 214 (78 percent) presented with clinical stage I disease. Modified unilateral and bilateral template dissections were performed in 257 (94 percent) and 17 (6 percent) patients, respectively. Overall, 148 (54 percent) men had PS I and 126 (46 percent) PS-II disease.

Adjuvant chemotherapy was given to 13 patients (10 percent) with PS-II disease. Thirty-three (23 percent) men had recurrence over a median follow-up of 55 months.

Twenty-one (19 percent) of the 113 patients with PS-II disease who did not receive chemotherapy experienced disease relapse. Moreover, 81 percent were cured with surgery alone and never had recurrence. The primary endpoint did not differ between modified and bilateral template dissections.

“Modified unilateral template dissection provided excellent oncologic control while minimizing morbidity,” the authors said.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Elvira Manzano, Yesterday
Monthly injections of the PCSK9* monoclonal antibody evolocumab effectively reduced plasma LDL-cholesterol (LDL-C), often referred to as the bad cholesterol, in teenagers with heterozygous familial hypercholesterolaemia (HeFH) already taking statins, with or without ezetimibe, the HAUSER-RCT has shown.
Jairia Dela Cruz, Yesterday
For individual with type 2 diabetes, losing weight is everything when it comes to improving the metabolic function, and it matters little whether this is achieved by dieting or undergoing bariatric surgery, according to a small study.
Jairia Dela Cruz, 16 Sep 2020
In patients with heart failure with reduced ejection fraction (HFrEF) receiving angiotensin-converting-enzyme (ACE) inhibitors, high dosing confers benefits for the risk of death or hospitalization that are similar to that obtained with lower dosing, according to a systematic review and meta-analysis.
Pearl Toh, 21 Sep 2020
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.